6446.TW
PharmaEssentia Corporation
TaiwanTWDEQUITY
Healthcare
DELAYED
Buy
+23/100
Last price
1,205.00
▲ 30.00 (2.55%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
1,180.00
Prev close
1,175.00
Day high
1,215.00
Day low
1,165.00
Volume
1.48M
Market cap
$498.53B
P/E (TTM)
69.37
52W range
407.92 – 1,645.00
Day trading desk
Gap from prior close
+0.43%
Prior close 1,175.00
VWAP
1,195.28
+0.81% from price
Relative volume
0.40×
Quiet session
Session range
4.29%
1,165.00 – 1,215.00
Position in range
80%
Near session high
ATR (14D)
43.57
3.62% of price
Prior day high
1,225.00
PDH
Prior day low
1,170.00
PDL
Bid / ask spread
—
Quote not published
Session volume
1.37M
Avg 3.45M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.82%
-2.8%
1M
-8.02%
-9.2%
3M
-12.64%
-17.2%
6M
+106.28%
+88.1%
YTD
+184.40%
+170.2%
1Y
+170.04%
+153.6%
3Y
+320.81%
+238.6%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 6446.TW open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
51.41M
Total on file
Fundamentals
Market cap$498.53B
Enterprise value$463.51B
Revenue (TTM)$20.75B
Gross profit$18.86B
EBITDA$8.14B
Net income$7.63B
EPS (TTM)$17.37
Free cash flow$2.68B
Total cash$24.47B
Total debt$1.02B
Book value / share$88.84
Shares outstanding413.71M
Float330.92M
Short % of float—
Dividend yield0.13%
Beta (5Y)0.65
Valuation & profitability ratios
Trailing P/E69.37
Forward P/E29.19
PEG ratio—
Price / sales—
Price / book13.56
EV / revenue22.34
EV / EBITDA56.92
Gross margin90.90%
Operating margin45.98%
Profit margin36.76%
Return on equity23.34%
Return on assets12.95%
Debt / equity2.78
Current ratio5.28
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $15.63B | $9.73B | $5.11B | $2.88B | +60.6% |
| Operating revenue | $15.63B | $9.73B | $5.11B | $2.88B | +60.6% |
| Cost of revenue | $1.68B | $1.18B | $610.54M | $812.29M | +43.1% |
| Gross profit | $13.95B | $8.56B | $4.50B | $2.07B | +63.0% |
| Research & development | $3.47B | $2.59B | $2.22B | $1.43B | +34.0% |
| Selling, general & admin | $5.55B | $4.23B | $4.18B | $2.67B | +31.2% |
| Total operating expense | $9.02B | $6.82B | $6.41B | $4.10B | +32.3% |
| Operating income | $4.93B | $1.74B | -$1.91B | -$2.03B | +183.9% |
| Net interest income | $616.99M | $895.26M | $538.44M | $21.91M | -31.1% |
| Pre-tax income | $4.98B | $2.99B | -$986.93M | -$1.84B | +66.4% |
| Tax provision | -$62.23M | $29.15M | -$363.10M | -$467.06M | -313.5% |
| Net income | $5.05B | $2.97B | -$623.84M | -$1.37B | +70.1% |
| Net income to common | $5.05B | $2.97B | -$623.84M | -$1.37B | +70.1% |
| Basic EPS | 12.30 | 7.27 | -1.57 | -3.93 | +69.2% |
| Diluted EPS | 12.25 | 7.21 | -1.57 | -3.93 | +69.9% |
| EBIT | $5.01B | $3.02B | -$940.24M | -$1.82B | +66.0% |
| EBITDA | $5.41B | $3.38B | -$671.49M | -$1.60B | +59.8% |
| Basic shares | 410.15M | 407.90M | 396.97M | 349.86M | +0.6% |
| Diluted shares | 411.72M | 411.17M | 396.97M | 349.86M | +0.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $22.69B | $21.05B | $19.67B | $10.30B | +7.8% |
| Cash & short-term investments | $22.72B | $21.07B | $19.69B | $11.28B | +7.8% |
| Accounts receivable | $4.47B | $2.62B | $1.31B | $798.65M | +70.5% |
| Inventory | $1.30B | $1.28B | $1.46B | $1.10B | +1.7% |
| Total current assets | $29.04B | $25.42B | $22.90B | $13.37B | +14.3% |
| Property, plant & equipment | $5.29B | $3.56B | $2.84B | $1.05B | +48.6% |
| Goodwill & intangibles | $235.12M | $272.72M | $267.91M | $236.88M | -13.8% |
| Total assets | $37.41B | $31.06B | $27.27B | $15.33B | +20.4% |
| Total current liabilities | $4.68B | $2.56B | $2.15B | $2.55B | +83.0% |
| Current debt | $6.00M | $11.94M | $33.37M | $1.01B | -49.7% |
| Long-term debt | $44.83M | $50.81M | $62.71M | $74.98M | -11.8% |
| Total debt | $856.06M | $965.47M | $1.20B | $1.57B | -11.3% |
| Total liabilities | $5.44B | $3.59B | $3.32B | $3.19B | +51.3% |
| Retained earnings | $6.95B | $2.97B | -$631.19M | -$4.19B | +133.6% |
| Shareholder equity | $31.98B | $27.47B | $23.95B | $12.14B | +16.4% |
| Working capital | $24.36B | $22.86B | $20.74B | $10.82B | +6.6% |
| Net tangible assets | $31.74B | $27.20B | $23.68B | $11.90B | +16.7% |
| Shares issued | 421.11M | 408.00M | 418.86M | 372.32M | +3.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | $4.98B | $2.99B | -$986.93M | -$1.84B | — | +66.4% |
| Depreciation & amortisation | $398.60M | $367.71M | $268.76M | $227.92M | — | +8.4% |
| Stock-based compensation | $463.47M | $164.39M | $710.21M | $216.21M | — | +181.9% |
| Change in working capital | -$333.27M | -$698.22M | -$681.02M | -$109.97M | — | +52.3% |
| Operating cash flow | $5.28B | $2.52B | -$709.51M | -$1.51B | — | +109.0% |
| Capital expenditure | -$1.92B | -$903.50M | -$1.33B | -$320.75M | — | -112.9% |
| Investing cash flow | -$2.48B | -$1.33B | -$486.65M | -$1.24B | — | -85.4% |
| Share buybacks | — | $0 | -$2.72B | $0 | -$87.50M | — |
| Dividends paid | -$366.17M | — | — | — | — | — |
| Financing cash flow | -$499.93M | -$163.02M | $10.45B | $9.58B | — | -206.7% |
| Free cash flow | $3.35B | $1.62B | -$2.04B | -$1.83B | — | +106.9% |
| End cash position | $22.69B | $21.05B | $19.67B | $10.30B | — | +7.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $6.86B | $5.12B | $4.88B | — | $3.60B | $3.26B | +33.9% |
| Operating revenue | $6.86B | $5.12B | $4.88B | — | $3.60B | $3.26B | +33.9% |
| Cost of revenue | $395.45M | $621.28M | $543.67M | — | $450.20M | $362.52M | -36.3% |
| Gross profit | $6.46B | $4.50B | $4.34B | — | $3.15B | $2.89B | +43.6% |
| Research & development | $1.07B | $857.29M | $1.01B | — | $828.53M | $747.24M | +24.4% |
| Selling, general & admin | $2.24B | $1.56B | $1.77B | — | $1.23B | $1.04B | +43.8% |
| Total operating expense | $3.30B | $2.41B | $2.78B | — | $2.06B | $1.79B | +36.9% |
| Operating income | $3.16B | $2.09B | $1.56B | — | $1.10B | $1.11B | +51.2% |
| Net interest income | $142.08M | $134.82M | $130.23M | — | $166.75M | $201.84M | +5.4% |
| Pre-tax income | $3.20B | $2.34B | $2.01B | — | $95.82M | $1.46B | +37.0% |
| Tax provision | $668.64M | $185.95M | $536.45M | — | -$736.43M | $196.92M | +259.6% |
| Net income | $2.53B | $2.15B | $1.48B | — | $832.25M | $1.26B | +17.7% |
| Net income to common | $2.53B | $2.15B | $1.48B | — | $832.25M | $1.26B | +17.7% |
| Basic EPS | 5.53 | 5.22 | — | 3.60 | 1.83 | 3.08 | +5.9% |
| Diluted EPS | 5.53 | 5.21 | — | 3.58 | 1.82 | 3.07 | +6.1% |
| EBIT | $3.20B | $2.34B | $2.02B | — | $104.65M | $1.47B | +36.9% |
| EBITDA | $3.33B | $2.46B | $2.12B | — | $202.93M | $1.56B | +35.4% |
| Basic shares | 457.82M | 412.01M | — | 409.54M | 454.78M | 409.29M | +11.1% |
| Diluted shares | 457.82M | 412.75M | — | 411.60M | 457.03M | 410.99M | +10.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $24.47B | $24.18B | $22.69B | — | $20.78B | $22.03B | +1.2% |
| Cash & short-term investments | $24.49B | $24.20B | $22.72B | — | $20.80B | $22.06B | +1.2% |
| Accounts receivable | $5.63B | $4.78B | $4.47B | — | $3.26B | $2.91B | +18.0% |
| Inventory | $1.27B | $1.22B | $1.30B | — | $1.16B | $1.38B | +4.5% |
| Total current assets | $33.59B | $30.92B | $29.04B | — | $25.77B | $26.90B | +8.6% |
| Property, plant & equipment | $6.32B | $5.93B | $5.29B | — | $4.05B | $3.83B | +6.6% |
| Goodwill & intangibles | $1.31B | $224.26M | $235.12M | — | $259.95M | $269.58M | +484.3% |
| Total assets | $44.11B | $40.09B | $37.41B | — | $32.80B | $33.02B | +10.0% |
| Total current liabilities | $6.36B | $4.74B | $4.68B | — | $3.34B | $2.97B | +34.3% |
| Current debt | $6.12M | $6.01M | $6.00M | — | $8.73M | $10.35M | +1.9% |
| Long-term debt | $41.84M | $43.34M | $44.83M | — | $47.82M | $49.32M | -3.4% |
| Total debt | $1.02B | $961.19M | $856.06M | — | $944.51M | $984.99M | +6.3% |
| Total liabilities | $7.29B | $5.64B | $5.44B | — | $4.26B | $3.90B | +29.4% |
| Retained earnings | $9.75B | $9.10B | $6.95B | — | $4.00B | $4.24B | +7.2% |
| Shareholder equity | $36.82B | $34.45B | $31.98B | — | $28.55B | $29.12B | +6.9% |
| Working capital | $27.22B | $26.19B | $24.36B | — | $22.43B | $23.93B | +4.0% |
| Net tangible assets | $35.51B | $34.23B | $31.74B | — | $28.29B | $28.85B | +3.7% |
| Shares issued | 423.31M | 421.42M | 421.11M | 421.23M | 421.21M | — | +0.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | $3.20B | $2.34B | $2.01B | $95.82M | $1.46B | +37.0% |
| Depreciation & amortisation | $123.12M | $117.16M | $104.99M | $98.28M | $96.63M | +5.1% |
| Stock-based compensation | $261.25M | $44.48M | $412.95M | $18.76M | $24.58M | +487.3% |
| Change in working capital | -$751.06M | -$793.14M | -$611.71M | $62.78M | -$497.32M | +5.3% |
| Operating cash flow | $2.39B | $1.73B | $1.91B | $70.50M | $1.06B | +38.1% |
| Capital expenditure | -$386.27M | -$579.06M | -$1.04B | -$308.00M | -$226.75M | +33.3% |
| Investing cash flow | -$2.15B | -$525.20M | -$1.12B | -$317.71M | -$283.91M | -308.9% |
| Dividends paid | — | — | $0 | — | — | — |
| Financing cash flow | $84.36M | -$14.88M | $11.90M | -$43.44M | -$46.90M | +666.9% |
| Free cash flow | $2.01B | $1.16B | $874.94M | -$237.49M | $834.63M | +73.9% |
| End cash position | $24.47B | $24.18B | $22.69B | $20.78B | $22.03B | +1.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 6.23 | 6.13 | -1.7% |
| Mar 2026 | 3.83 | 5.21 | +36.2% |
| Dec 2025 | 3.58 | 3.58 | -0.1% |
| Sep 2025 | 3.89 | 3.60 | -7.4% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 6.52 | 3 | $7.60B | +95.1% |
| Next quarter | 7.58 | 3 | $8.76B | +79.4% |
| Current year | 27.46 | 7 | $28.58B | +82.8% |
| Next year | 41.28 | 8 | $41.51B | +45.2% |
Analyst targets & ownership
Mean target$1,482.61
High target$2,143.00
Low target$555.00
Implied upside23.04%
Analyst count8
ConsensusBUY
Strong buy / Buy3 / 4
Hold1
Sell / Strong sell0 / 0
Held by insiders12.40%
Held by institutions21.52%
Institutions holding197
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
1,180.50
+2.08% from price
SMA 20
1,214.00
-0.74% from price
SMA 50
1,292.30
-6.76% from price
SMA 100
1,153.54
+4.46% from price
SMA 200
859.90
+40.13% from price
EMA 12
1,195.66
+0.78% from price
EMA 26
1,232.34
-2.22% from price
EMA 50
1,234.23
-2.37% from price
RSI (14)
46.4
Neutral
MACD (12,26,9)
-36.69
Hist 3.11
ATR (14)
43.57
3.62% of price
Realised vol 30D
55.9%
Annualised
Bollinger upper
1,348.45
20, 2σ
Bollinger lower
1,079.55
20, 2σ
50 / 200 cross
Golden
1,292.30 vs 859.90
Trend bias
Above 200
+40.13%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.16
Less volatile than market
Correlation to SPY
0.04
Largely independent
Realised vol 30D
55.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.4%
Peak to trough
Max drawdown 5Y
-53.7%
Peak to trough
ATR 14
43.57
3.62% of price
Beta (reported)
0.65
5Y monthly, from filing
Dividends & splits
Forward rate$1.49 / yr
Forward yield0.13%
5-year avg yield—
Payout ratio5.14%
Ex-dividend dateJul 9, 2026
Next pay date—
Last split1109.2778:1000
Split dateJul 9, 2026
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.